11
Jo Anne GoodnightSBIR/STTR Program Coordinator
Office of Extramural Research, NIH
NIH SBIR/STTR NIH SBIR/STTR Funding Funding
OpportuOpportu“NIH”“NIH”tietie$$
Nat
ion
al In
stit
ute
s o
f H
ealt
h
11th Annual NIH SBIR/STTR ConferenceJune 30 – July 1, 2009
Omaha, Nebraska
22
CONFERENCE GOALSCONFERENCE GOALS
We really ARE here to help you Understand NIH SBIR/STTR Program and Funding Opportunities Understand NIH application, review and award process better More confident about submitting a competitive application Take advantage of the one-on-one and networking opportunities Enjoy yourself!
OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR
Topics to DiscussTopics to Discuss
• SBIR/STTR Program Overview SBIR/STTR Program Overview • NIH SBIR/STTR Program SpecificsNIH SBIR/STTR Program Specifics• Solicitations and Funding Opportunities Solicitations and Funding Opportunities • The NIH Peer-Review Process The NIH Peer-Review Process • Industry- University Partnership Industry- University Partnership OpportunitiesOpportunities• Gap-Funding Programs Gap-Funding Programs • Transitioning to the MarketplaceTransitioning to the Marketplace
44
SBIR/STTR Program Overview
SMALL BUSINESS INNOVATION SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAMRESEARCH (SBIR) PROGRAM
Set-aside program for small business concerns to engage in Federal R&D -- with potential for commercialization.
SMALL BUSINESS TECHNOLOGY SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMTRANSFER (STTR) PROGRAM
Set-aside program to facilitate cooperative R&D between small business concerns and U.S. research institutions -- with potential for commercialization.
2.5%
0.3%
SBIR/STTR Program Overview
55
SBIR Purpose and Goals
Small Business Innovation Development Act of 1982P.L. 106-554 (Signed 12/21/2000 extends program through 09/30/2008)
• Stimulate technological innovation
• Use small business to meet Federal R&D needs
• Foster and encourage participation by minorities and disadvantaged persons in technological innovation
• Increase private-sector commercialization innovations derived from Federal R&D
“We in government must work in partnership with small businesses to ensure that technologies and processes are readily transferred to commercial applications.” – Ronald Reagan, July 22, 1982.
SBIR/STTR Program Overview
66
SBIR Program Extended Temporarily Until July 31, 2009
P.L. 111-10 temporarily extends programs authorized under the Small Business Act and the Small Business Investment Act of 1958. (Extension includes SBIR)
-- signed into law on March 19, 2009
SBIR/STTR Program Overview
SBIR Program Update
77
• S.1233: A bill to reauthorize and improve the SBIR and STTR programs and for other purposes. Introduced Jun 10, 2009
• H.R. 2747: To amend the Small Business Act to improve outreach and support activities and to increase award recipients from rural areas with respect to the Small Business Innovation Research Program and the Small Business Technology Transfer Program, and for other purposes. Introduced Jun 8, 2009
• H.R. 2769: Commercializing Small Business Research and Development Act Introduced Jun 9, 2009
• H.R. 2767: Investing in Tomorrow's Technology Act
Introduced Jun 9, 2009• H.R. 2772: SBIR and STTR Enhancement Act
Introduced Jun 9, 2009
•
SBIR Legislative Update
SBIR/STTR Program Overview
88
STTR Purpose and Goals
Small Business Research and Development Enhancement Act of 1992
P.L. 107-50 (Program reauthorized through 09/30/2009)
• Stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions
• Foster technology transfer between small business concerns and research institutions
SBIR/STTR Program Overview
99
The largest, most accessible source of
SEED CAPITAL for the nation’s innovative
small businesses~$2.3 Billion in 2009
SBIR/STTR Programs25 years later…
DOD SBIR/STTRHHS SBIR/STTRNASA SBIR/STTRDOE SBIR/STTRNSF SBIR/STTRDHS SBIRUSDA SBIRDOC SBIRED SBIREPA SBIRDOT SBIR
$670M
1010
…and
This capital is in the form ofgrants and contracts
no repaymentno debt service
no equity forfeiture no IP forfeiture
SBIR/STTR Program Overview
1111
•PHASE II Full Research/R&D $750K and 2-year Award (SBIR & STTR) Pre-requisite: Phase I award
•PHASE III Commercialization Stage Use of non-SBIR/STTR Funds
• PHASE I Feasibility Study $100K and 6-month (SBIR) or 12-month (STTR)
Award
SBIR/STTR: 3-Phase Program
SBIR/STTR Program Overview
1212 SBIR/STTR Program Overview
1313
SBIR Eligibility Criteria
Applicant must be a Small Business Concern
Organized as for-profit U.S. business
Small: 500 or fewer employees, including affiliates
PD/PI’s primary employment must be with small business concern at time of award and for duration of project period (unless a waiver is granted)
At least 51% U.S.- owned by individuals and independently operated or
At least 51% owned and controlled by another (one) business concern that is at least 51% owned and controlled by one or more individuals
SBIR/STTR Program Overview
1414
Applicant must be a Small Business Concern
Formal Cooperative R&D Effort
• Minimum 40% by small business• Minimum 30% by U.S. research institution
U.S. Research Institution
• College or University; other non-profit research organization; Federal R&D center
Intellectual Property Agreement
• Allocation of rights in IP and rights to carry out follow-on R&D and commercialization
STTR Eligibility Criteria
SBIR/STTR Program Overview
1515
STTR Research Institution Partner
• U.S. non-profit organization owned and operated exclusively for scientific or educational purposes
• U.S. non-profit medical and surgical hospitalseligible as partner as long as these
institutions are exclusively engaged in scientific research and/or application of scientific principles and techniques
SBIR/STTR Program Overview
1616
PI Eligibility on STTR
• PD/PI is not required to be employed by SBC
• PD/PI at RI must establish contract between RI and SBC describing PD/PI’s involvement
• PD/PI must commit a minimum of 10% effort
• PD/PI’s “signature” on application is agreement to conforming to Solicitation requirements
SBIR/STTR Program Overview
1717
PI Eligibility on STTR
• PD/PI is not required to be employed by SBC
• PD/PI at RI must establish contract between RI and SBC describing PD/PI’s involvement
• PD/PI must commit a minimum of 10% effort
• PD/PI’s “signature” on Face Page is agreement to conforming to Solicitation requirements
SBIR/STTR Program Overview
1818
• Research Partner SBIR: Permits partnering
STTR: Requires partnering with Research Institution
Small Business Concern is ALWAYSSmall Business Concern is ALWAYSApplicant/Awardee OrganizationApplicant/Awardee Organization
SBIR vs STTR: Which Program is Best for You?
Consider major differences• Principal Investigator SBIR: Primary employment
must be with small business concern
STTR: PI may be employed by research institution or small business concern
SBIR/STTR Program Overview
1919
Important Facts to Remember
• Eligibility is determined at time of award
• PD/PI is not required to have a Ph.D./M.D.
• PD/PI is required to have expertise to oversee project scientifically and technically
• Applications may be submitted to different agencies for similar work
• Awards may not be accepted from different agencies for duplicative projects
SBIR/STTR Program Overview
OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR
Topics to Discuss TodayTopics to Discuss Today
• SBIR/STTR Program Overview SBIR/STTR Program Overview • NIH SBIR/STTR Program SpecificsNIH SBIR/STTR Program Specifics• Solicitations and Funding Opportunities Solicitations and Funding Opportunities • The NIH Peer-Review Process The NIH Peer-Review Process • Industry- University Partnership Industry- University Partnership OpportunitiesOpportunities• Gap-Funding Programs Gap-Funding Programs • Transitioning to the MarketplaceTransitioning to the Marketplace
2121
NIH Mission:Improve Human Health
Science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability—from the rarest genetic disorder to the common cold.
NIH SBIR/STTR Program Specifics
2222
• Improve human health through prevention, detection, diagnosis and treatment of disease or disability• Speed process of discovery• Reduce cost of medical care• Improve research tools/ reduce cost of research• Increase health knowledge base
SBIR/STTR Programs Are Fully Integrated Within NIH Research Agenda
Bridging the Discovery to Bridging the Discovery to Development GapDevelopment Gap
NIH SBIR/STTR Program Specifics
2323
Office of the Director
National Center on Minority Health
and Health Disparities
Organizational Structure of NIH
http://www.nih.gov/icd
National Instituteon Alcohol Abuseand Alcoholism
National Instituteof Arthritis andMusculoskeletal
and Skin Diseases
National CancerInstitute
National Instituteon Aging
National Instituteof Child Health
and HumanDevelopment
National Instituteof Allergy and
Infectious Diseases
National Instituteof Diabetes andDigestive and
Kidney Diseases
National Instituteof Dental andCraniofacial
Research
National Instituteon Drug Abuse
National Instituteof Environmental Health Sciences
National Institute onDeafness and Other
CommunicationDisorders
National EyeInstitute
National HumanGenome Research
Institute
National Heart,Lung, and Blood
Institute
National Instituteof Mental Health
National Instituteof NeurologicalDisorders and
Stroke
National Instituteof General
Medical Sciences
National Instituteof Nursing Research
National Libraryof Medicine
National Centerfor Complementary
and AlternativeMedicine
FogartyInternational
Center
National Centerfor ResearchResources
National Instituteof Biomedical
Imaging and
Bioengineering
No funding authority
2424
NIH Institute/Center SBIR/STTR Budget Allocations (FY2009)
$600 M (SBIR) $ 72 M (STTR)
Total: $672 M
NIDDKNIGMS
NIH SBIR/STTR Program Specifics
Extramural R&D Set-Asides:SBIR = 2.5%STTR = 0.3%
2525
• PHASE II Full Research/R&D Average $850K and 2-years
• PHASE II Competing Renewal/R&D Clinical R&D; Complex Instrumentation/Tools Some, but not all, ICs participate $1M/year; 3 years
• PHASE III Commercialization Stage NIH, generally, not the “customer” Consider exit strategy early
• PHASE I Feasibility Study Average award: $170K Project Period: Most awards on a 1-yr NCE
NIH SBIR/STTR: 3-Phase Program
NIH SBIR/STTR Program Specifics
2626
Phase I Phase II Phase III
Gap Funding Programs
Mt. “FDA”
• No-Cost Extension• Phase I / Phase II Fast Track• Administrative / Competitive Supplements
Phase II Competing Renewal Award
NIH SBIR/STTR Program Specifics
2727
(Simultaneous Submission and Concurrent Review)
SBIR/STTR Phase I + Phase II
Phase I Award
7-9 months
Completion of Phase I Phase I Final Report Program Staff assess completion of specific aims and milestones
Phase II award
Aims/Milestones Met
Phase II award
Aims/MilestonesAims/MilestonesNOT MetNOT Met
Go?
No Go?
NIH Phase I/Phase II Fast-Track
NIH SBIR/STTR Program Specifics
2828
Important Considerations• Convincing preliminary data
• Clear, measurable, achievable milestones
• Well-conceived Commercialization Plan
• Letters of Phase III support/interest?
• Track record for commercializing?
• Discussed with NIH Program Staff?
NIH Phase I/Phase II Fast-Track
NIH SBIR/STTR Program Specifics
OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR
Topics to Discuss TodayTopics to Discuss Today
• SBIR/STTR Program Overview SBIR/STTR Program Overview • NIH SBIR/STTR Program SpecificsNIH SBIR/STTR Program Specifics• Solicitations and Funding Opportunities Solicitations and Funding Opportunities • The NIH Peer-Review Process The NIH Peer-Review Process • Industry- University Partnership Industry- University Partnership OpportunitiesOpportunities• Gap-Funding Programs Gap-Funding Programs • Transitioning to the MarketplaceTransitioning to the Marketplace
3030
• NIH, CDC & FDA SBIR/STTR Grant Solicitation
Release: January Standard Due Dates: April 5, Aug 5, Dec 5(AIDS/AIDS-related: May 7, Sept 7, Jan 7)
• SBIR Contract Solicitation (NIH, CDC)Release: August November receipt date
• NIH Guide for Grants and ContractsRelease: Weekly Receipt dates specified in each FOA
(http://grants.nih.gov/grants/guide/index.html)
Solicitations and Due Dates
“Parent” FOAs: SBIR: PA-09-080 STTR: PA-09-081
Solicitations and Funding Opportunities
http://grants.nih.gov/grants/funding/sbir.htm
3131
Small Businesses can apply for NIH Recovery Act funding opportunities:
Challenge Grants (RC1) Grand Opportunities [“GO” Grants] (RC2) Administrative Supplements Competing Supplements (“Revisions”) Biomedical Research, Development and Growth [BRDG-SPAN] (RC3) Catalyst Awards (R43)
SBIR/STTR and ARRA
NIH Recovery Act Funding Opportunities:http://grants.nih.gov/recovery/
Solicitations and Funding Opportunities
3232
http://grants.nih.gov/grants/funding/sbir.htm
NIH SBIR/STTR Web Site
Solicitation and Funding Opportunities
3333
NIH SBIR/STTR Solicitation Research Topics
Our IdeasOur Ideas**
Biodefense
Biosensors
Nanotechnologies
Bioinformatics
Diagnostic and Therapeutic Devices
Telehealth
Biosilicon devices
Biocompatible materials
Acousto-optics / opto-electronics
Imaging devices
Genetically engineered proteins
Proteomics / Genomics
*Examples from 200+ pages of topics!
Parent SolicitationsSBIR: PA-09-080 and STTR: PA-09-081
3434
Investigator-initiated IdeasInvestigator-initiated Ideas(a.k.a. “I can’t find a topic match”)(a.k.a. “I can’t find a topic match”)• Research projects related to NIH mission• “Other” areas of research within mission of an awarding component
NIH SBIR/STTR Research Topics
Keyword search the Solicitation
Ctrl - FSolicitations and Funding Opportunities
3535
Common Application Problems
• No Significance Unimportant problem, unconvincing case for
commercial potential or societal impact• Inadequately defined test of feasibility• Lack of innovation • Diffuse, superficial, or unfocused research plan
Lack of sufficient experimental detail• Questionable reasoning in experimental approach
Failure to consider potential pitfalls and alternatives• Lack of experience with essential methodologies• Unfamiliar with relevant published work• Unrealistically large amount of work proposed
Solicitations and Funding Opportunities
3636
• Identifying Funding Opportunities• Electronic Submission Using Grants.gov and the NIH eRA Commons
Solicitations and Funding Opportunity Announcements
Solicitations and Funding Opportunities
3737
Small Business Concern
Applicant Initiates
Research Idea
Grantee Conducts Research
IC Staff Prepare funding Planfor IC Director
NIH Center for Scientific ReviewAssign to IC and IRG
Scientific Review GroupsEvaluate Scientific Merit
Advisory Council or BoardRecommend approval
IC Allocates
Funds
SubmitsSBIR/STTR Grant Application to NIH
Electronically
~2-3 monthsafter submission
~2-3 months
after review
NIH Application and Review Process
Solicitations and Funding Opportunities
3838
Timeline: New Applications
DueDueDateDate
April 5April 5
August 5August 5
December 5December 5
ScientificReview
July
October
March
CouncilReview
October
January
May
AwardDate (earliest)
December
April
July
2.52.5 1.71.7 2.22.2
<……………….……6-9 months…………………….>
Solicitations and Funding Opportunities
3939
• An In-Depth Look at the NIH SBIR/STTR Receipt, Referral, and Review Process • All You Ever Wanted to Know About the Electronic Submission Process
NIH Application Submissionand Review Process
Solicitations and Funding Opportunities
4040
05
101520253035404550
SBIR STTR
Phase I
Phase II
Fast-Track
NIH SBIR/STTR Success Rates:FY 2008
Su
cces
s R
ate
(%) $650 M
SBIR/STTR
739
288
46
66
109
48.3%
32%
16%
39%
9.5%
27.2%4
Solicitations and Funding Opportunities
4141
• Preparing a Successful Application• Pre-Award and Post Award Issues• Indirect Cost Rates and Accounting Systems: Workshop
Solicitations and Funding Opportunities
OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR
Topics to Discuss TodayTopics to Discuss Today
• SBIR/STTR Program Overview SBIR/STTR Program Overview • NIH SBIR/STTR Program SpecificsNIH SBIR/STTR Program Specifics• Solicitations and Funding Opportunities Solicitations and Funding Opportunities • The NIH Peer-Review Process The NIH Peer-Review Process • Industry- University Partnership Industry- University Partnership OpportunitiesOpportunities• Gap-Funding Programs Gap-Funding Programs • Transitioning to the MarketplaceTransitioning to the Marketplace
4343
SBIR/STTR Historical Relationships
1997
FederalGovernment
SmallBusinesses
1982
Industry-University Partnerships
4444
Quasi-Government Corporations Economic Development Entities Technology Centers State Venture Funds
StateGovernment
19981982
SmallBusinesses
FederalGovernment
SBIR/STTR Historical Relationships
Industry-University Partnerships
4545
SBIR/STTR Historical Relationships
2000- 20091982
SmallBusinesses
Academia University Research Parks Faculty & Graduate Students Technology Incubators Research Foundations University Start-Ups
Quasi-Government Corporations Economic Development Entities Technology Centers
StateGovernmentFederal
Government
Industry-University Partnerships
4646
University Start-Ups:Roles in the SBIR/STTR Programs
• University is the intellectual capital of scientific and engineering knowledge
• Small Business is a vehicle forchanneling scientific discovery to thebenefit of society
• Partnership between the University and the Small Business benefitsBOTH
Industry-University Partnerships
4747
University-Business Partnership Opportunities
• Own small firms (assign someone else PI)
• Principal Investigator (with official permission from university)
• Senior Personnel on SBIR/STTR
• Consultants on SBIR/STTR
• Subcontracts on SBIR/STTR
• University facilities provide analytical and other service support
Industry-University Partnerships
4848
University and Industry:Two diverse cultures
Industry Researchers Industry Researchers
are from MARS!are from MARS!
University Researchers University Researchers
are from Venus!are from Venus!
Industry-University Partnerships
4949
University cultureUniversity culture
• Research, discover, educate and train future
workforce• Pace is slower - aligned to academic cycle
• Mission = basic and applied research• Technology transfer activities are companion
to applied research mission
• Fertile ground for economic development
University and Industry:Two diverse cultures
Industry-University Partnerships
5050
Industry cultureIndustry culture
• Mission toward research/R&D/commercialization
• Quick-paced
• Solve problems - develop new products profit
• Maintain control of science to explore full potential of discovery (initially)
• Economic impact: Jobs, societal benefit
University and Industry:Two diverse cultures
Industry-University Partnerships
5151
Cultural Diversity
University - Industry PartnershipsUniversity - Industry Partnerships Critical dimension of the new “Innovation-based Economy”
Universities are establishing creative and entrepreneurial environments for the commercialization of university intellectual property
Universities and Industry learning to work together
is KEY!
Industry-University Partnerships
5252
• Develop common goals between faculty-initiated business and mission of research institution
• Create environment that enables innovation and entrepreneurship
• Protect IP assets of university
• Establish policies to manage, reduce or eliminate conflict of interest (COI)
Entrepreneurial Research Institution
Key Ingredients
Industry-University Partnerships
5353
• The Ohio State University
• Purdue University
• University of Wisconsin
• N.C. State University
• Georgia Tech
• Virginia Tech
Examples of Successful Entrepreneurial
Research Institutions• Texas A&M University
• Penn. State University
• UC San Diego
• University of Utah
• Carnegie Mellon
University
• Stanford University
Source: Innovation U. “New University Roles in A Knowledge Economy”Southern Technology Council and Southern Growth Policies Board
http://www.southern.org/pubs/pubs_pdfs/iu_report.pdf
Industry-University Partnerships
5454
• Texas A&M
Allows commercialization of faculty research to be considered in the granting of tenure to faculty at A&M System universities.
Examples of Successful Entrepreneurial Research
Institutions (cont.)
Industry-University Partnerships
5555
Endocyte, Inc. (Purdue Research Park)
Researcher, Dr. Philip Low, discovered way to diagnose, potentially cure, ovarian cancer using vitamin folate
Sell technology or start own company to develop and market treatment????
Resisted VC offers initially…. wanted control of science Also exploring use of folate in arthritis
University Start-Up Success Story
Industry-University Partnerships
5656
• Faculty entrepreneur Dr. Phil Low , along with CEO, Ron Ellis, and angel investor Jack Clawson found Endocyte
• NIH SBIR Funding
• $1.63 M from NCI + 1.95M from Indiana 21st Century Res & Technology Fund
• Multiple rounds of financing received
• Collaborations with Bristol-Myers Squibb
• Endocyte has a strong pipeline with a number of products in various stages of clinical and preclinical development.
BENEFIT: Purdue retained his talent.
ADVICE: Hire experienced CEO to handle all but science.
Unversity Start-Up Success Story (cont)
5757
• Ivory Tower Innovation & University Start-Ups • Tools for Building and Facilitating Partnerships
OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR
Topics to Discuss TodayTopics to Discuss Today
• SBIR/STTR Program Overview • NIH SBIR/STTR Program Specifics• Solicitations and Funding Opportunities • The NIH Peer-Review Process • Industry- University Partnership Opportunities• Gap-Funding Programs Gap-Funding Programs • Transitioning to the MarketplaceTransitioning to the Marketplace
5959
Phase I Phase II Phase III
Challenges for Biotech Firms: Navigating the Peaks and Valleys
Unusually long
development times (5-12
yrs)
High & intense
capital needs (>$1B)
Exceptionally high burn rate for investment
funds
Multiple rounds of financing required
Transitioning to the Marketplace
6060
In-NIH-vative Approaches to Overcoming Commercialization
Challenges
• Phase II Competing Renewal Awards
• BRDG-SPAN Awards • Technical Assistance Program
• Finding a Partner
6161
Phase I Phase II Phase III
Mt. “FDA”????
Phase II Competing Renewal Awards
Gap Funding and Transitioning to the Market
6262
• To take existing, promising compounds or devices developed under a Phase II through the next step of drug discovery / medical device refinement and development (see Solicitation)
Purpose
OR….
• To support complex instrumentation, clinical research tools, behavior interventions/treatments (http://grants.nih.gov/grants/guide/pa-files/PA-08-115.html)
Phase II Competing Renewal Award
Gap Funding and Transitioning to the Market
6363
• SBIR Phase II awardee• Promising pharmacologic compound identified in original Phase II• Device prototype developed in original Phase II• Instrumentation/Interventional technologies not subject to FDA regulatory approval but require extraordinary time/effort to develop
Contact NIH Program Staff to discussContact NIH Program Staff to discuss
Eligibility
Parameters
• Maximum of $1M/year for up to 3 years • IC must accept Competing Renewal applications (NIA, NIAAA, NIAID, NIDA, NIDCD, NIDDK, NEI, NHLBI, NIMH, NICHD, NINDS, NIGMS and NCRR)
Phase II Competing Renewal Award
Gap Funding and Transitioning to the Market
6464
Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies
(BRDG-SPAN) Pilot Program
Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program
Application Due Date: September 1, 2009
Activity Code: RC3 (Not SBIR/STTR)
Purpose: To address the funding gap between promising research and development (R&D) and transitioning to the market -- often called the “Valley of Death -- by contributing to the critical funding needed to pursue the next appropriate milestone(s) toward ultimate commercialization; i.e., to carry out later stage research activities necessary to that end.
Budget/Project Period: $1 million total costs per year for a maximum of three years.
Eligible Institutions/Organizations. A U.S.-owned, for-profit enterprise/commercial organization doing a majority of its business in the United States.
6565
Technical Assistance Programs
Commercialization Assistance
Business & strategic planning
Builds alliances and investor partnerships(Phase II awardees)
Niche Assessment Identify other uses of technology
Determines competitive advantages
Develops market entry strategy
(Phase I awardees)
ManufacturingAssistance(Phase II awardees)
Partnership with NIST MEP Centers
Help make better manufacturing and operational decisions
Transitioning to the Marketplace
6666
NIH Pipeline to Partnerships(Ph I and Ph II awardees)
Finding a Partner
• Showcase of SBIR/STTR and NIH-licensed technologies
• Facilitates matchmaking between NIH SBIR/STTR awardees and potential strategic partners and investors
• Searches by application category (diagnostics, therapeutic, tool, etc.) and/or disease
Gap Funding and Transitioning to the Market
6767
Pipeline to Partnerships (P2P)http://www.ott.nih.gov/p2p/index.asp
6868
Pipeline to Partnerships (P2P)
http://www.ott.nih.gov/p2p/index.asp
Potential partner identifies technology of interest and contacts company's Web site.
Transitioning to the Marketplace
6969
Pipeline to Partnerships (P2P)http://www.ott.nih.gov/p2p/index.asp
Gap Funding and Transitioning to the Market
7070
Pipeline to Partnerships (P2P)
Potential partner identifies technology of interest and contacts company's Web site.
Gap Funding and Transitioning to the Market
7171
Pipeline to Partnerships (P2P)
http://www.ott.nih.gov/p2p/index.asp
Gap Funding and Transitioning to the Market
7272
Pipeline to Partnerships (P2P)
Gap Funding and Transitioning to the Market
7373
Phase I Phase II Phase III
NIH Technical Assistance Program
Mt. “FDA”???Commercialization Assistance Program
Niche Assessment Program
Helping Companies cross the “Valley of Death”
“In-NIH-vative” Approaches
7474
• Business Planning Basics• Strategies for Commercialization• Life Science Venture Funds and Angels• Building Corporate Alliances & Partnerships• Commercialization of Behavioral Services Interventions and Products• Moving from R&D to Manufacturing • Commercializing Your Healthcare/IT/Media Product
To Market We Go
7575
Top 10 Reasons
7676
Top 10 Reasons
10. Over $2.3 Billion available- annually
9. NOT A LOAN - no repayment
8. Provides recognition, verificationand visibility
7. Potential leveraging tool to attract venture capital/other sources of $$$
7777
5. Creates jobs / stimulates local and state economies – stronger National Economy
4. Provides seed money to fund high risk projects
6. Foster partnerships (universities, large corporations) that enhance
competitiveness of small businesses in marketplace
Top 10 Reasons
7878
3. Intellectual property rights arenormally retained by the smallbusiness
2. Small business concerns are recognized as a unique national resource of technological innovation – creating AND sustaining
Top 10 Reasons
7979
BrainGateTM SystemCyberkinetics Neurotechnology Systems, Inc.
Percutaneous Ventricular Assist DeviceTM
Cardiac Assist, Inc.
Next Generation TherapeuticsTM
GlycoFi, Inc.
Intralase CorporationFemtosecond LaserIntralase Corporation
PediSedateTM
Design Continuum, Inc.
1. Opportunity to make important contributions
to the health of AmAmerericaica
Top 10 Reasons
8080
Stay Informed…
NIH Guide for Grants and Contracts (weekly notification)
http://grants.nih.gov/grants/guide/listserv.htm
NIH SBIR/STTR Notification
Send email to [email protected] with the following text in the message body:
subscribe listname your name.
ListServes
OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR
For More InformationFor More Information
www.nih.govwww.nih.govhttp://grants.nih.gov/grants/funding/sbir.htm
Jo Anne GoodnightNIH SBIR/STTR Program Coordinator
Phone: 301- 435-2688 Fax: 301- 480-0146
Email: [email protected]
Kay EtzlerSBIR/STTR Program Analyst Email: [email protected]
Lenka FedorkovaSBIR/STTR Program Analyst
Email: [email protected]
8686
Thank You!
Questions?